bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.06.01.494307

Scalable graph analysis tools for the connectomics community

Matelsky, J. K.·Johnson, E. C.·Wester, B.·Gray-Roncal, W. R.
View original source ↗Export metadata ↓

Abstract

Neuroscientists now have the opportunity to analyze synaptic resolution connectomes that are larger than the memory on single consumer workstations. As dataset size and tissue diversity have grown, there is increasing interest in conducting comparative connectomics research, including rapidly querying and searching for recurring patterns of connectivity across brain regions and species. There is also a demand for algorithm reuse -- applying methods developed for one dataset to another volume. A key technological hurdle is enabling researchers to efficiently and effectively query these diverse datasets, especially as the raw image volumes grow beyond terabyte sizes. Existing community tools can perform such queries and analysis on smaller scale datasets, which can fit locally in memory, but the path to scaling remains unclear. Existing solutions such as neuPrint or FlyBrainLab enable these queries for specific datasets, but there remains a need to generalize algorithms and standards across datasets. To overcome this challenge, we present a software framework for comparative connectomics and graph discovery to make connectomes easy to analyze, even when larger-than-RAM, and even when stored in disparate datastores. This software suite includes visualization tools, a web portal, a connectivity and annotation query engine, and the ability to interface with a variety of data sources and community tools from the neuroscience community. These tools include MossDB (an immutable datastore for metadata and rich annotations); Grand (for prototyping larger-than-RAM graphs); GrandIso-Cloud (for querying existing graphs that exceed the capabilities of a single work-station); and Motif Studio (for enabling the public to query across connectomes). These tools interface with existing frameworks such as neuPrint, graph databases such as Neo4j, and standard data analysis tools such as Pandas or NetworkX. Together, these tools enable tool and algorithm reuse, standardization, and neuroscience discovery.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Matelsky, J. K., Johnson, E. C., Wester, B., Gray-Roncal, W. R.. 2022-06-02. Scalable graph analysis tools for the connectomics community. https://doi.org/10.1101/2022.06.01.494307

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗